Predicted protein targets (top 1)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TAAR1 | Q96RJ0 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL15445250 | 1.00 | TAAR1 (0.31) | TAAR1 | |
| SCHEMBL15445249 | 1.00 | TAAR1 (0.31) | TAAR1 | |
| SCHEMBL14700457 | 1.00 | TAAR1 (0.31) | TAAR1 | |
| SCHEMBL14700454 | 1.00 | TAAR1 (0.31) | TAAR1 | |
| SCHEMBL15445251 | 1.00 | TAAR1 (0.31) | TAAR1 | |
| SCHEMBL14700532 | 0.96 | TAAR1 (0.33) | TAAR1 | |
| SCHEMBL15451145 | 0.93 | ALDH1A1 (0.32) | — | |
| SCHEMBL12526896 | 0.93 | ALDH1A1 (0.32) | — | |
| SCHEMBL14700474 | 0.93 | — | — | |
| SCHEMBL15445256 | 0.93 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9527737-B2 | Carbon nanotube manufacturing method | NATIONAL UNIVERSITY CORPORATION NAGOYA UNIVERSITY (JP) | 2016-12-27 | — | — | US | disclosed |
| US-9266909-B2 | Cyclic compound containing functional group or containing no functional group, and method for producing same | NATIONAL UNIVERSITY CORPORATION NAGOYA UNIVERSITY (JP) | 2016-02-23 | — | — | US | disclosed |
| US-20150126779-A1 | CYCLIC COMPOUND CONTAINING FUNCTIONAL GROUP OR CONTAINING NO FUNCTIONAL GROUP, AND METHOD FOR PRODUCING SAME | NATIONAL UNIVERSITY CORPORATION NAGOYA UNIVERSITY (JP) | 2015-05-07 | — | — | US | disclosed |
| US-20140030183-A1 | CARBON NANOTUBE MANUFACTURING METHOD | NATIONAL UNIVERSITY CORPORATION NAGOYA UNIVERSITY (JP) | 2014-01-30 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20150126779-A1 | CYCLIC COMPOUND CONTAINING FUNCTIONAL GROUP OR CONTAINING NO FUNCTIONAL GROUP, AND METHOD FOR PRODUCING SAME | CYP1B1, BCR, DDT | TAAR1 1295/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.